Stéphanie Gaillard - Concepedia

Author

Stéphanie Gaillard

Also Known As

S Gaillard, S. Gaillard, S.L. Gaillard, Stephanie Gaillard, Stephanie L Gaillard, Stephanie L. Gaillard, Stéphanie Gaillard, Stéphanie Gaillard, Stéphanie L. Gaillard

295

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Duke Medical Center Sidney Kimmel Comprehensive Cancer Center Duke University

About

Stéphanie Gaillard is an author at Johns Hopkins University specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	2.9K
2	Health Sciences	5	5	226
3	Natural Sciences	4	4	1.3K
4	Public Health	3	3	455
5	Biochemistry	3	3	312

Stéphanie Gaillard

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor Jeffrey J. Kovacs, Patrick J. Murphy, Stéphanie Gaillard, Molecular Cell Signal TransductionMolecular RegulationNatural SciencesReceptor (Biochemistry)Molecular Biology	2005	1.1K
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024 Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsCancer ManagementGynecologyPathologyGynecology Oncology	2023	303
Estrogen-related Receptors Stimulate Pyruvate Dehydrogenase Kinase Isoform 4 Gene Expression Yi Zhang, Ke Ma, Prabodh Sadana, Journal of Biological Chemistry Insulin SignalingOxidative StressPdc ActivityMetabolic SyndromeTranscriptional Regulation	2006	159
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules Yu Yu, Stéphanie Gaillard, Jude M. Phillip, Cancer Cell MedicinePharmacologyCancer GrowthAnti-cancer AgentCancer Treatment	2015	140
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy Youngran Park, M. Herman Chui, Yohan Suryo Rahmanto, Clinical Cancer Research	2019	139
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma. Amir A. Jazaeri, Emese Zsíros, Rodabe N. Amaria, Journal of Clinical Oncology Cell TherapySurgical OncologyCancer ManagementImmunologyAutologous Tumor	2019	131
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer Payal D. Shah, Stephanie L. Wethington, Cheyenne Pagan, Gynecologic Oncology	2021	111
Identification and Structure−Activity Relationship of Phenolic Acyl Hydrazones as Selective Agonists for the Estrogen-Related Orphan Nuclear Receptors ERRβ and ERRγ William J. Zuercher, Stéphanie Gaillard, Lisa A. Orband‐Miller, Journal of Medicinal Chemistry	2005	103
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? Amanda N. Fader, Jennifer Bergstrom, Amelia Jernigan, Gynecologic Oncology Gynecologic SurgerySurgical OncologyPrimary Cytoreductive SurgeryGynecological SurgeryMedicine	2017	98
Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRγ Esther Y. Chao, Jon L. Collins, Stéphanie Gaillard, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryTamoxifen AnalogsNatural SciencesStructure-guided Synthesis	2005	95

Page 1